Plus Therapeutics (NASDAQ:PSTV – Get Rating) had its target price lowered by Maxim Group from $30.00 to $12.00 in a report issued on Wednesday, The Fly reports. Separately, HC Wainwright reissued a buy rating and set a $52.50 price target on shares of Plus Therapeutics in a report on Friday, April 21st. Plus Therapeutics Stock […]